627 related articles for article (PubMed ID: 27220674)
1. Intraperitoneally administered IgG from patients with amyotrophic lateral sclerosis or from an immune-mediated goat model increase the levels of TNF-α, IL-6, and IL-10 in the spinal cord and serum of mice.
Obál I; Klausz G; Mándi Y; Deli M; Siklós L; Engelhardt JI
J Neuroinflammation; 2016 May; 13(1):121. PubMed ID: 27220674
[TBL] [Abstract][Full Text] [Related]
2. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
3. Passive transfer of purified IgG from patients with amyotrophic lateral sclerosis to mice results in degeneration of motor neurons accompanied by Ca2+ enhancement.
Pullen AH; Demestre M; Howard RS; Orrell RW
Acta Neuropathol; 2004 Jan; 107(1):35-46. PubMed ID: 14551798
[TBL] [Abstract][Full Text] [Related]
4. Experimental Motor Neuron Disease Induced in Mice with Long-Term Repeated Intraperitoneal Injections of Serum from ALS Patients.
Obál I; Nógrádi B; Meszlényi V; Patai R; Ricken G; Kovacs GG; Tripolszki K; Széll M; Siklós L; Engelhardt JI
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31130623
[TBL] [Abstract][Full Text] [Related]
5. Subcellular localization of IgG from the sera of ALS patients in the nervous system.
Engelhardt JI; Soós J; Obál I; Vigh L; Siklós L
Acta Neurol Scand; 2005 Aug; 112(2):126-33. PubMed ID: 16008539
[TBL] [Abstract][Full Text] [Related]
6. Altered calcium homeostasis and ultrastructure in motoneurons of mice caused by passively transferred anti-motoneuronal IgG.
Engelhardt JI; Siklos L; Appel SH
J Neuropathol Exp Neurol; 1997 Jan; 56(1):21-39. PubMed ID: 8990126
[TBL] [Abstract][Full Text] [Related]
7. Recruitment of activated microglia cells in the spinal cord of mice by ALS IgG.
Obál I; Jakab JS; Siklós L; Engelhardt JI
Neuroreport; 2001 Aug; 12(11):2449-52. PubMed ID: 11496127
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
Han Y; Ripley B; Serada S; Naka T; Fujimoto M
PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
[TBL] [Abstract][Full Text] [Related]
9. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
[TBL] [Abstract][Full Text] [Related]
10. Passive Transfer of Blood Sera from ALS Patients with Identified Mutations Results in Elevated Motoneuronal Calcium Level and Loss of Motor Neurons in the Spinal Cord of Mice.
Polgár TF; Meszlényi V; Nógrádi B; Körmöczy L; Spisák K; Tripolszki K; Széll M; Obál I; Engelhardt JI; Siklós L; Patai R
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576165
[No Abstract] [Full Text] [Related]
11. Serine proteases purified from sera of patients with amyotrophic lateral sclerosis (ALS) induce contrasting cytopathology in murine motoneurones to IgG.
Demestre M; Howard RS; Orrell RW; Pullen AH
Neuropathol Appl Neurobiol; 2006 Apr; 32(2):141-56. PubMed ID: 16599943
[TBL] [Abstract][Full Text] [Related]
12. Neutral Lipid Cacostasis Contributes to Disease Pathogenesis in Amyotrophic Lateral Sclerosis.
Dodge JC; Jensen EH; Yu J; Sardi SP; Bialas AR; Taksir TV; Bangari DS; Shihabuddin LS
J Neurosci; 2020 Nov; 40(47):9137-9147. PubMed ID: 33051352
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Re Attenuates Neuroinflammation in a Symptomatic ALS Animal Model.
Cai M; Yang EJ
Am J Chin Med; 2016; 44(2):401-13. PubMed ID: 27080948
[TBL] [Abstract][Full Text] [Related]
14. Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation.
Varghese AM; Ghosh M; Bhagat SK; Vijayalakshmi K; Preethish-Kumar V; Vengalil S; Chevula PC; Nashi S; Polavarapu K; Sharma M; Dhaliwal RS; Philip M; Nalini A; Alladi PA; Sathyaprabha TN; Raju TR
J Neuroinflammation; 2020 Aug; 17(1):232. PubMed ID: 32762702
[TBL] [Abstract][Full Text] [Related]
15. Sporadic amyotrophic lateral sclerosis: is SMN-Gemins protein complex of importance for the relative resistance of oculomotor nucleus motoneurons to degeneration?
Sulejczak D; Chrapusta SJ; Dziewulska D; Rafałowska J
Folia Neuropathol; 2018; 56(4):308-320. PubMed ID: 30786668
[TBL] [Abstract][Full Text] [Related]
16. The role of immune processes in amyotrophic lateral sclerosis pathogenesis.
Alexianu ME
Rom J Neurol Psychiatry; 1995; 33(3-4):215-27. PubMed ID: 8729177
[TBL] [Abstract][Full Text] [Related]
17. IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients.
Fiala M; Chattopadhay M; La Cava A; Tse E; Liu G; Lourenco E; Eskin A; Liu PT; Magpantay L; Tse S; Mahanian M; Weitzman R; Tong J; Nguyen C; Cho T; Koo P; Sayre J; Martinez-Maza O; Rosenthal MJ; Wiedau-Pazos M
J Neuroinflammation; 2010 Nov; 7():76. PubMed ID: 21062492
[TBL] [Abstract][Full Text] [Related]
18. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue.
Henkel JS; Engelhardt JI; Siklós L; Simpson EP; Kim SH; Pan T; Goodman JC; Siddique T; Beers DR; Appel SH
Ann Neurol; 2004 Feb; 55(2):221-35. PubMed ID: 14755726
[TBL] [Abstract][Full Text] [Related]
19. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
20. Long-term interleukin-33 treatment delays disease onset and alleviates astrocytic activation in a transgenic mouse model of amyotrophic lateral sclerosis.
Korhonen P; Pollari E; Kanninen KM; Savchenko E; Lehtonen Š; Wojciechowski S; Pomeshchik Y; Van Den Bosch L; Goldsteins G; Koistinaho J; Malm T
IBRO Rep; 2019 Jun; 6():74-86. PubMed ID: 30705990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
